Edgar Filing: ALTERA CORP

Altera_2012Q3_10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)



[x]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 28, 2012



[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

Commission file number 0-16617




ALTERA CORPORATION
(Exact name of registrant as specified in its charter)



DELAWARE		77-0016691
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

101 INNOVATION DRIVE

SAN JOSE, CALIFORNIA 95134

(Address of principal executive offices) (zip code)

408-544-7000

(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:



Large accelerated filer [x]	Accelerated filer [ ]	Non-accelerated filer [ ]	Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [x]

Number of shares of common stock outstanding at October 10, 2012: 320,572,559



	PAGE NUMBER

PART I FINANCIAL INFORMATION

ITEM 1. Financial Statements (Unaudited)

Consolidated Balance Sheets	3

Consolidated Statements of Comprehensive Income	4

Consolidated Statements of Cash Flows	5

Notes to Consolidated Financial Statements	6

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	19

ITEM 3. Quantitative and Qualitative Disclosures about Market Risk	26

ITEM 4. Controls and Procedures	28

PART II OTHER INFORMATION

ITEM 1. Legal Proceedings	28

ITEM 1A. Risk Factors	28

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds	29

ITEM 6. Exhibits	30

Signatures	31


Exhibit 31.1
Exhibit 31.2
Exhibit 32.1
Exhibit 32.2
EX-101 Instance Document
EX-101 Schema Document
EX-101 Calculation Linkbase Document
EX-101 Label Linkbase Document
EX-101 Presentation Linkbase Document
EX-101 Definition Linkbase Document

Table of Contents

PART I FINANCIAL INFORMATION


ITEM 1:	Financial Statements

ALTERA CORPORATION

CONSOLIDATED BALANCE SHEETS

(Unaudited)



(In thousands, except par value amount)	September 28, 2012		December 31, 2011
Assets
Current assets:
Cash and cash equivalents	$	2,849,829	$	3,371,933
Short-term investments	144,195		65,222
Total cash, cash equivalents, and short-term investments	2,994,024		3,437,155
Accounts receivable, net	348,273		232,273
Inventories	157,848		122,279
Deferred income taxes — current	65,223		58,415
Deferred compensation plan — marketable securities	58,151		54,041
Deferred compensation plan — restricted cash equivalents	18,524		17,938
Other current assets	42,134		52,710
Total current assets	3,684,177		3,974,811
Property and equipment, net	200,172		171,721
Long-term investments	685,945		74,033
Deferred income taxes — non-current	23,047		26,629
Other assets, net	49,519		35,074
Total assets	$	4,642,860	$	4,282,268
Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$	45,589	$	52,154
Accrued liabilities	39,183		34,029
Accrued compensation and related liabilities	43,563		78,181
Deferred compensation plan obligations	76,675		71,979
Deferred income and allowances on sales to distributors	400,351		279,876
Credit facility	—		500,000
Total current liabilities	605,361		1,016,219
Income taxes payable — non-current	261,843		263,423
Long-term debt	500,000		—
Other non-current liabilities	9,496		8,730
Total liabilities	1,376,700		1,288,372
Commitments and contingencies
(See “Note 11 — Commitments and Contingencies”)
Stockholders' equity:
Common stock: $.001 par value; 1,000,000 shares authorized; outstanding - 320,563 shares at September 28, 2012 and 322,054 shares at December 31, 2011	321		322
Capital in excess of par value	1,107,614		1,050,752
Retained earnings	2,151,627		1,942,955
Accumulated other comprehensive income (loss)	6,598		(133		)
Total stockholders' equity	3,266,160		2,993,896
Total liabilities and stockholders' equity	$	4,642,860	$	4,282,268

See accompanying notes to consolidated financial statements.

Table of Contents

ALTERA CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)



	Three Months Ended						Nine Months Ended
(In thousands, except per share amounts)	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011
Net sales	$	495,010		$	522,474		$	1,343,595		$	1,606,671
Cost of sales	152,007			166,938			408,156			473,565
Gross margin	343,003			355,536			935,439			1,133,106
Research and development expense	91,606			80,771			266,259			235,438
Selling, general, and administrative expense	74,243			69,345			215,824			208,550
Compensation expense (benefit) — deferred compensation plan	3,274			(6,642		)	6,697			(4,926		)
(Gain) loss on deferred compensation plan securities	(3,274		)	6,642			(6,697		)	4,926
Interest income and other	(2,775		)	(663		)	(5,997		)	(2,505		)
Loss/(gain) reclassified from other comprehensive income	108			—			(63		)	—
Interest expense	2,333			806			5,386			2,717
Income before income taxes	177,488			205,277			454,030			688,906
Income tax expense	19,999			19,873			18,028			64,806
Net income	157,489			185,404			436,002			624,100

Other comprehensive income:
Unrealized gain on investments:
Unrealized holding gain on investments arising during period, net of tax of $43 and $108	3,620			—			6,723			—
Less: Reclassification adjustments for gain on investments included in net income, net of tax of $1, and $6	(41		)	—			(64		)	—
	3,579			—			6,659			—
Unrealized gain on derivatives:
Unrealized (loss)/gain on derivatives arising during period, net of tax of $6 and $36	(10		)	—			67			—
Less: Reclassification adjustments for loss on derivatives included in net income, net of tax of $53, and $2	97			—			5			—
	87			—			72			—
Other comprehensive income	3,666			—			6,731			—
Comprehensive income	$	161,155		$	185,404		$	442,733		$	624,100

Net income per share:
Basic	$	0.49		$	0.58		$	1.36		$	1.94
Diluted	$	0.49		$	0.57		$	1.34		$	1.90

Shares used in computing per share amounts:
Basic	319,870			321,745			321,200			322,012
Diluted	323,560			327,044			325,275			328,264

Cash dividends per common share	$	0.10		$	0.08		$	0.26		$	0.20

See accompanying notes to consolidated financial statements.

Table of Contents

ALTERA CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)



	Nine Months Ended
	September 28, 2012			September 30, 2011

Cash Flows from Operating Activities:
Net income	$	436,002		$	624,100
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	26,426			23,443
Stock-based compensation	70,790			59,983
Deferred income tax benefit	(3,367		)	(9,549		)
Tax effect of employee stock plans	14,381			26,077
Excess tax benefit from employee stock plans	(20,790		)	(22,959		)
Changes in assets and liabilities:
Accounts receivable, net	(116,000		)	(23,228		)
Inventories	(35,569		)	12,496
Other assets	5,478			47,986
Accounts payable and other liabilities	(34,670		)	(40,004		)
Deferred income and allowances on sales to distributors	120,475			11,115
Income taxes payable	(650		)	30,122
Deferred compensation plan obligations	(2,001		)	(345		)
Net cash provided by operating activities	460,505			739,237
Cash Flows from Investing Activities:
Purchases of property and equipment	(53,712		)	(23,178		)
Proceeds from sales of deferred compensation plan securities, net	2,001			345
Purchases of available-for-sale securities	(819,662		)	(130,146		)
Proceeds from sale and maturity of available-for-sale securities	135,650			1,750
Purchases of intangible assets	(2,280		)	—
Purchases of other investments	(4,510		)	—
Net cash used in investing activities	(742,513		)	(151,229		)
Cash Flows from Financing Activities:
Proceeds from issuance of common stock through various stock plans	37,514			93,619
Shares withheld for employee taxes	(30,529		)	(31,122		)
Payment of dividends to stockholders	(83,570		)	(64,328		)
Proceeds from issuance of long-term debt	500,000			—
Repayment of credit facility	(500,000		)	—
Long-term debt and credit facility issuance costs	(5,244		)	—
Repurchases of common stock	(179,057		)	(197,018		)
Excess tax benefit from employee stock plans	20,790			22,959
Net cash used in financing activities	(240,096		)	(175,890		)
Net (decrease) increase in cash and cash equivalents	(522,104		)	412,118
Cash and cash equivalents at beginning of period	3,371,933			2,765,196
Cash and cash equivalents at end of period	$	2,849,829		$	3,177,314

See accompanying notes to consolidated financial statements.

Table of Contents

ALTERA CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 — Organization and Basis of Presentation

The accompanying unaudited consolidated financial statements of Altera Corporation and its subsidiaries, collectively referred to herein as “Altera”, “we”, “us”, or “our”, have been prepared by us in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. This financial information reflects all adjustments which are, in the opinion of our management, of a normal recurring nature and necessary for a fair statement of the results for the periods presented. The December 31, 2011 consolidated balance sheet data was derived from our audited consolidated financial statements included in our 2011 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission (“SEC”), but does not include all disclosures required by U.S. GAAP. The consolidated financial statements include our accounts as well as those of our wholly-owned subsidiaries after elimination of all significant inter-company balances and transactions.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

These consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2011 included in our Annual Report on Form 10-K. The consolidated operating results for the three or nine months ended September 28, 2012 are not necessarily indicative of the results to be expected for any future period.

Note 2 — Recent Accounting Pronouncements

In June 2011, the FASB issued ASU 2011-05, Comprehensive Income (Topic 220), Presentation of Comprehensive Income, which requires companies to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. This update eliminates the option to present the components of other comprehensive income as part of the statement of equity. In December 2011, the FASB issued ASU 2011-12, Comprehensive Income (Topic 220), Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in ASU 2011-05, to defer the effective date of the specific requirement to present items that are reclassified out of accumulated other comprehensive income to net income alongside their respective components of net income and other comprehensive income. We adopted the guidance in our first quarter of 2012 with no significant impact on our consolidated financial statements or related footnotes.

Table of Contents

Note 3 — Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables summarize our cash and available-for-sale securities by significant investment category.



	September 28, 2012
(In thousands)	Cost		Unrealized Gains		Unrealized Losses			Fair Value		Cash and Cash Equivalents		Short-Term Marketable Securities		Long-Term Marketable Securities

Cash	$	39,112	$	—	$	—		$	39,112	$	39,112	$	—	$	—

Available for sale:
Level 1:
Money market funds	2,744,850		—		—			2,744,850		2,744,850		—		—
U.S. treasury securities	579,281		6,113		(1		)	585,393		35,446		32,382		517,565
Subtotal	3,324,131		6,113		(1		)	3,330,243		2,780,296		32,382		517,565

Level 2:
U.S. agency securities	107,799		43		(3		)	107,839		27,278		40,470		40,091
Non-U.S. government securities	11,813		15		(2		)	11,826		—		6,253		5,573
Municipal bond	1,370		2		—			1,372		—		752		620
Corporate securities	189,133		484		(40		)	189,577		3,143		64,338		122,096
Subtotal	310,115		544		(45		)	310,614		30,421		111,813		168,380
Total	$	3,673,358	$	6,657	$	(46	)	$	3,679,969	$	2,849,829	$	144,195	$	685,945

Table of Contents



	December 31, 2011
(In thousands)	Cost		Unrealized Gains		Unrealized Losses			Fair Value		Cash and Cash Equivalents		Short-Term Marketable Securities			Long-Term Marketable Securities

Cash	$	165,122	$	—	$	—		$	165,122	$	165,122	$	—		$	—

Available for sale:
Level 1:
Money market funds	3,189,462		—		—			3,189,462		3,189,462		—			—
U.S. treasury securities	6,199		—		—			6,199		—		6,199			—
Corporate securities	12,999		—		—			12,999		10,999		2,000			—
Subtotal	3,208,660		—		—			3,208,660		3,200,461		8,199		—	—

Level 2:
U.S. agency securities	41,167		11		(7		)	41,171		750		25,890			14,531
Non-U.S. government securities	8,221		—		(8		)	8,213		—		8,213			—
Municipal bond	754		—		(1		)	753		—		—			753
Corporate securities	87,415		84		(230		)	87,269		5,600		22,920			58,749
Subtotal	137,557		95		(246		)	137,406		6,350		57,023			74,033
Total	$	3,511,339	$	95	$	(246	)	$	3,511,188	$	3,371,933	$	65,222		$	74,033

During the three months ended September 28, 2012, we made certain cost method investments of approximately $4.5 million. These investments are included within Other assets, net in our consolidated balance sheets.

The adjusted cost and estimated fair value of marketable debt securities (corporate bonds, municipal bonds, U.S. and foreign government securities, and U.S. treasury securities) as of September 28, 2012, by contractual maturity, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations without call or prepayment penalties.



(In thousands)	Cost		Estimated Fair Value
Due in one year or less	$	210,020	$	210,059
Due after one year through five years	679,373		685,945
	$	889,393	$	896,004

Derivative Financial Instruments

We use derivative financial instruments primarily to manage foreign currency exchange rate risk. Substantially all of our operational expenditures are transacted in U.S. dollars. However, operating expenditures of our subsidiaries are incurred in or exposed to other currencies, primarily the Malaysian Ringgit. We hedge portions of the forecasted foreign currency exposure associated with operational expenditures in Malaysia generally up to three months in advance. We record all derivatives at fair value. These forward foreign currency exchange contracts were designated and qualified as cash flow hedges, and the effective portion of the gain or loss on the forward contracts was reported as a component of other comprehensive income and reclassified into net income in the same period during which the hedged transaction affected earnings.

Table of Contents

The notional amount of our outstanding foreign exchange contracts was $7.8 million as of September 28, 2012. The outstanding forward currency exchange contracts expire at various dates between October 2012 and December 2012. We did not have any hedging activities as of December 31, 2011. These derivative instruments are classified within Level 2 of the fair value hierarchy, as they are not actively traded and are valued using pricing models that use observable market inputs.

Note 4 — Accounts Receivable, Net and Significant Customers

Accounts receivable, net was comprised of the following:



(In thousands)	September 28, 2012			December 31, 2011
Gross accounts receivable	$	348,847		$	232,838
Allowance for doubtful accounts	(500		)	(500		)
Allowance for sales returns	(74		)	(65		)
Accounts receivable, net	$	348,273		$	232,273

We sell our products to original equipment manufacturers, or OEMs, and to electronic components distributors who resell these products to OEMs, or their subcontract manufacturers. Net sales by customer type and net sales to significant customers were as follows:



	Three Months Ended				Nine Months Ended
(Percentage of Net Sales)	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011

Sales to distributors	69	%	74	%	70	%	74	%
Sales to OEMs	31	%	26	%	30	%	26	%
	100	%	100	%	100	%	100	%

Significant Distributors⁽¹⁾:
Arrow Electronics, Inc. ( “Arrow”)	40	%	40	%	39	%	39	%
Macnica, Inc. (“Macnica”)	19	%	19	%	21	%	20	%


(1)	Except as presented above, no other distributor accounted for greater than 10% of our net sales for the quarterly or year-to-date periods ended September 28, 2012 or September 30, 2011.

One OEM accounted for 16% and 18% of our net sales for the quarterly and year-to-date periods ended September 28, 2012, respectively. The same OEM accounted for 12% and 13% for the quarterly and year-to-date periods ended September 30, 2011, respectively. No other individual OEM accounted for more than 10% of our net sales for the quarterly or year-to-date periods ended September 28, 2012 or September 30, 2011.

As of September 28, 2012, accounts receivable from Arrow and Macnica individually accounted for approximately 34% and 46%, respectively, of our gross accounts receivable. As of December 31, 2011, accounts receivable from Arrow, Macnica and Avnet, Inc. including its affiliates, individually accounted for approximately 30%, 43% and 11%, respectively, of our gross accounts receivable. No other distributor or OEM accounted for more than 10% of our accounts receivable as of September 28, 2012 or December 31, 2011. Accounts receivable from distributors may not be proportionate to net sales and may fluctuate on a quarterly basis due to varying factors, including inventory levels held by distributors and timing of price concessions and payments.

Table of Contents

Note 5 — Inventories

Inventories were comprised of the following:



(In thousands)	September 28, 2012		December 31, 2011
Raw materials	$	9,219	$	9,293
Work in process	103,902		71,696
Finished goods	44,727		41,290
Total inventories	$	157,848	$	122,279

Note 6 — Property and Equipment

Property and equipment, net was comprised of the following:



(In thousands)	September 28, 2012			December 31, 2011
Land and land rights	$	23,157		$	23,157
Buildings	158,612			148,323
Equipment and software	243,782			232,793
Office furniture and fixtures	24,012			23,440
Leasehold improvements	11,618			7,652
Construction in progress	2,043			5,836
Property and equipment, at cost	463,224			441,201
Accumulated depreciation and amortization	(263,052		)	(269,480		)
Property and equipment, net	$	200,172		$	171,721

Depreciation expense was $8.7 million and $23.7 million for the three months and nine months ended September 28, 2012 respectively. Depreciation expense was $7.4 million and $21.1 million for the three months and nine months ended September 30, 2011, respectively. Depreciation and amortization expense as presented in our consolidated statements of cash flows includes the above amounts, together with amortization expense on our intangible assets. Intangible asset amortization expense was not significant for any period presented in our consolidated statements of comprehensive income.

Note 7 — Deferred Income and Allowances on Sales to Distributors

Deferred income and allowances on sales to distributors was comprised of the following:



(In thousands)	September 28, 2012			December 31, 2011

Deferred revenue on shipment to distributors	$	422,826		$	302,815
Deferred cost of sales on shipment to distributors	(33,180		)	(30,536		)
Deferred income on shipment to distributors	389,646			272,279
Advances to distributors	—			(648		)
Other deferred revenue ⁽¹⁾	10,705			8,245
Total	$	400,351		$	279,876


(1)	Principally represents revenue deferred on our software and intellectual property licenses.

The Deferred income and allowances on sales to distributors activity for the nine months ended September 28, 2012 and September 30, 2011 was as follows:

Table of Contents



	Nine Months Ended
(In thousands)	September 28, 2012			September 30, 2011

Balance at beginning of period	$	279,876		$	428,711
Deferred revenue recognized upon shipment to distributors	4,006,945			3,992,638
Deferred cost of sales recognized upon shipment to distributors	(181,660		)	(227,189		)
Decrease in advances to distributors	648			63,803
Revenue recognized upon sell-through to end customers	(763,141		)	(979,877		)
Cost of sales recognized upon sell-through to end customers	176,455			224,933
Earned distributor price concessions ⁽¹⁾	(3,057,927		)	(2,952,593		)
Returns	(61,531		)	(111,851		)
Other	686			1,251
Balance at end of period	$	400,351		$	439,826


(1)	Average aggregate price concessions typically range from 65% to 80% of our list price on an annual basis, depending upon the composition of our sales, volumes and factors associated with timing of shipments to distributors.

Note 8 — Accumulated Other Comprehensive Income (Loss)

The following table presents the components of, and the changes in, accumulated other comprehensive income (loss), net of tax:



(In thousands)	December 31, 2011			Other Comprehensive Income		September 28, 2012

Accumulated unrealized (losses) gains on available-for-sale securities, net of tax	$	(133	)	$	6,659	$	6,526
Accumulated unrealized losses on hedging transactions, net of tax	—			72		72
Accumulated other comprehensive (loss) income	$	(133	)	$	6,731	$	6,598

Table of Contents

Note 9 — Income Per Share

A reconciliation of basic and diluted income per share is presented below:



	Three Months Ended				Nine Months Ended
(In thousands, except per share amounts)	September 28, 2012		September 30, 2011		September 28, 2012		September 30, 2011

Basic:

Net income	$	157,489	$	185,404	$	436,002	$	624,100
Basic weighted shares outstanding	319,870		321,745		321,200		322,012
Net income per share	$	0.49	$	0.58	$	1.36	$	1.94

Diluted:

Net income	$	157,489	$	185,404	$	436,002	$	624,100

Weighted shares outstanding	319,870		321,745		321,200		322,012
Effect of dilutive securities:
Stock options, ESPP, and restricted stock unit shares	3,690		5,299		4,075		6,252

Diluted weighted shares outstanding	323,560		327,044		325,275		328,264

Net income per share	$	0.49	$	0.57	$	1.34	$	1.90

In applying the treasury stock method, we excluded 1.7 million and 1.4 million stock option shares and restricted stock units for the three and nine months ended September 28, 2012, respectively, and 2.7 million and 1.4 million stock option shares and restricted stock units for the three and nine months ended September 30, 2011, respectively, because their effect was anti-dilutive. While these shares have been anti-dilutive, they could be dilutive in the future.

Note 10 — Credit Facility and Long-Term Debt

Credit Facility

In May 2012, we repaid in full the $500 million outstanding under our former credit agreement dated August 31, 2007.

On June 29, 2012, we entered into a five-year $250 million unsecured revolving credit facility (the "Facility"). Under certain circumstances, upon our request and with the consent of the lenders, the commitments under the Facility may be increased up to an additional $250 million. Borrowings under the Facility will bear interest at a base rate determined in accordance with the Facility, plus an applicable margin based upon the debt rating of our non-credit enhanced, senior unsecured long-term debt. In addition, we are obligated to pay a quarterly commitment fee, payable in arrears, based on the available commitments. This facility fee varies and is also determined based on our debt rating. The terms of the Facility require compliance with certain financial and non-financial covenants, which we have satisfied as of September 28, 2012. As of September 28, 2012, we have not borrowed any funds under the Facility.

Table of Contents

Long-term Debt

On May 8, 2012, we completed a public offering of $500 million aggregate principal amount of 1.75% senior notes that will mature on May 15, 2017 (the "Notes") with an effective interest rate of 1.91%. Interest on the Notes is payable semiannually in arrears on May 15 and November 15 of each year, beginning on November 15, 2012. The Notes are governed by a base and supplemental indenture between Altera and U.S. Bank National Association, as trustee. The Notes are our unsecured and unsubordinated obligations, ranking equally in right of payment to all of our existing and future unsecured and unsubordinated indebtedness and senior in right of payment to any of our future indebtedness that is expressly subordinated to the Notes. We may redeem the Notes, in whole or in part, at any time and from time to time for cash at the redemption prices described in the indenture.

We received net proceeds of $495.5 million from issuance of the Notes, after deduction of issuance costs of $3.7 million and a discount of $0.8 million. The debt issuance costs are recorded in other assets and are being amortized to interest expense over five years using the effective interest method. We used the net proceeds of the Notes to re-pay our former credit facility that was entered into on August 31, 2007.

The estimated fair value of Altera's long-term debt was approximately $515.7 million at September 28, 2012. Our long-term debt is classified within Level 1 of the fair value hierarchy and the estimated fair value of the debt is based on quoted market prices.

Note 11 — Commitments and Contingencies

Indemnification and Product Warranty

We indemnify certain customers, distributors, suppliers, and subcontractors for attorney's fees and damages and costs awarded against these parties in certain circumstances in which our products are alleged to infringe third party intellectual property rights, including patents, trade secrets, trademarks or copyrights. We cannot estimate the amount of potential future payments, if any, that we might be required to make as a result of these agreements. To date, we have not paid any claim or been required to defend any action related to our indemnification obligations, and, accordingly, we have not accrued any amounts for such indemnification obligations. However, we may record charges in the future as a result of these indemnification obligations.

We generally warrant our devices for one year against defects in materials, workmanship and material non-conformance to our specifications. We accrue for known warranty issues if a loss is probable and can be reasonably estimated, and accrue for estimated but unidentified issues based on historical activity. If there is a material increase in customer claims compared with our historical experience or if the costs of servicing warranty claims are greater than expected, we may record a charge against cost of sales. Warranty expense was not significant for any period presented in our consolidated statements of comprehensive income.

Purchase Obligations

We depend entirely upon subcontractors to manufacture our silicon wafers and provide assembly and test services. Due to lengthy subcontractor lead times, we must order these materials and services from these subcontractors well in advance, and we are obligated to pay for the materials and services once they are completed. As of September 28, 2012, we had approximately $136.7 million of outstanding purchase commitments to such subcontractors. We expect to receive and pay for these materials and services over the next six months.

Operating Leases

We lease facilities under non-cancelable lease agreements expiring at various times through 2021. There have been no significant changes to our operating lease obligations since December 31, 2011.

Legal Proceedings

On December 8, 2010, Intellectual Ventures I LLC and Intellectual Ventures II LLC (“Intellectual Ventures”) filed a lawsuit in the United States District Court for the District of Delaware against Altera, Microsemi Corporation, and Lattice Semiconductor Corporation alleging that Altera infringes five patents. The complaint requests unspecified monetary damages including enhanced damages for willful infringement. In February 2011, Intellectual Ventures filed a First Amended Complaint adding Xilinx, Inc. as a defendant. In March 2011, Altera answered the complaint and asserted counterclaims against Intellectual Ventures for non-infringement and invalidity of the asserted patents. The defendants filed motions in the District of Delaware to transfer the case to the United States District Court for the Northern District of California and to stay the action pending re-examination proceedings

Table of Contents

in the United States Patent and Trademark Office. Intellectual Ventures opposed the motions. In January 2012, the United States District Court for the District of Delaware denied the defendants' motion to transfer the case to the Northern District of California, and in February 2012, the court denied the defendants' motion to stay. Three of the four defendants, including Altera, filed a writ of mandamus in the Court of Appeals for the Federal Circuit requesting that the case be transferred to the Northern District of California. In July 2012, the Court of Appeals for the Federal Circuit denied the writ of mandamus. Because the case is at a very early stage, it is not possible for us to determine whether there is a reasonable possibility that a loss has been incurred nor can we estimate the range of potential loss. The case is currently scheduled for trial in May 2014.

We file income tax returns with the Internal Revenue Service (“IRS”) and in various states and foreign jurisdictions. In 2008, the IRS completed field examinations for 2002 through 2004 and proposed an additional tax liability of $34.5 million, excluding interest. We contested this proposed additional tax liability in the IRS Office of Appeals and resolved several of the issues. On December 8, 2011, the IRS issued a Statutory Notice of Deficiency, revising the assessment of additional taxes for 2002 through 2004 to $19.8 million, excluding interest. The Notice relates primarily to inter-company adjustments between related companies, computational adjustments to the research and development ("R&D") credit and reductions to the benefits of tax credit carrybacks and carryforwards to subsequent years. On March 6, 2012, we filed a petition in the U.S. Tax Court to request a redetermination of the tax deficiency regarding certain IRS adjustments for 2004. We deposited $18.0 million as a cash bond with the IRS in 2008, and converted this amount to tax payments in March 2012. On May 8, 2012, the IRS filed its petition response in the Tax Court, in which the IRS conceded the R&D credit adjustment for 2004. In June 2012, the federal statute of limitations for the 2002 and 2003 tax years expired.

In addition, in 2010 the IRS completed field examinations for 2005 through 2007 and proposed an additional tax liability of $34.2 million, excluding interest. On January 23, 2012, the IRS issued a Statutory Notice of Deficiency, revising the assessment of additional taxes for 2005 through 2007 to $21.4 million, excluding interest. The Notice relates primarily to intercompany adjustments between related companies and reductions to the benefits of tax credit carrybacks and carryforwards to subsequent years. On April 20, 2012, we filed a petition in the U.S. Tax Court to request a redetermination of the tax deficiencies regarding certain IRS adjustments for 2005 through 2007. On June 21, 2012, the IRS filed its petition response in the Tax Court.

On August 15, 2012, the case for the 2004 tax year was combined with that for the 2005 through 2007 tax years. The case is currently scheduled for trial in March 2013. We believe we have made adequate tax payments and/or accrued adequate amounts for our tax liabilities for 2004 through 2007 and that the outcome of the above matters will not have a material adverse effect on our consolidated operating results, cash flows or financial position.

Note 12 — Stock-Based Compensation

Our stock-based compensation plans include the 2005 Equity Incentive Plan (the “2005 Plan”) and the 1987 Employee Stock Purchase Plan (the “ESPP”).

2005 Plan

Our equity incentive program is a broad-based, long-term retention program intended to attract, motivate, and retain talented employees as well as align stockholder and employee interests. The 2005 Plan provides stock-based incentive compensation (“awards”) to both our eligible employees and non-employee directors. Awards that may be granted under the 2005 Plan include non-qualified and incentive stock options, restricted stock units (“RSU”s), performance-based restricted stock units (“PRSU”s), restricted stock awards, stock appreciation rights, and stock bonus awards. To date, awards granted under the 2005 Plan consist of stock options, RSUs and PRSUs. The majority of stock-based awards granted under the 2005 Plan vest over four years. Stock options granted under the 2005 Plan have a maximum contractual term of ten years. As of September 28, 2012, the 2005 Plan had a total of 29.1 million shares reserved for future issuance, of which 22.0 million shares were available for future grants.

Table of Contents

A summary of activity for our RSUs and PRSUs for the nine months ended September 28, 2012 and information regarding RSUs and PRSUs outstanding and expected to vest as of September 28, 2012 is as follows:



(In thousands, except per share amounts and terms)	Number of Shares		Weighted-Average Grant-Date Fair Market Value Per Share		Weighted-Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value ⁽¹⁾
Outstanding, December 31, 2011	8,176		$	31.62
Grants	2,057		$	34.12
Vested	(2,851	)	$	27.34
Forfeited	(565	)	$	31.93
Outstanding, September 28, 2012	6,817		$	34.15	1.66	$	231,766
Vested and expected to vest, September 28, 2012	5,953		$	34.15	1.59	$	202,390

Table of Contents


(1)	Aggregate intrinsic value represents the closing price per share of our stock on September 28, 2012, multiplied by the number of RSUs and PRSUs outstanding or vested and expected to vest as of September 28, 2012.

A summary of stock option activity for the nine months ended September 28, 2012 and information regarding stock options outstanding, exercisable, and vested and expected to vest as of September 28, 2012 is as follows:



(In thousands, except per share amounts and terms)	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value ⁽¹⁾
Outstanding, December 31, 2011	6,138		$	22.96
Grants	707		$	34.43
Exercises	(1,505	)	$	18.81
Forfeited/Cancelled/Expired	(44	)	$	32.50
Outstanding, September 28, 2012	5,296		$	25.59	4.20	$	51,658
Exercisable, September 28, 2012	3,950		$	21.75	2.60	$	50,064
Vested and expected to vest, September 28, 2012	5,107		$	25.17	4.00	$	51,535


(1)	For those stock options with an exercise price below the closing price per share on September 28, 2012, aggregate intrinsic value represents the difference between the exercise price and the closing price per share of our common stock on September 28, 2012, multiplied by the number of stock options outstanding, exercisable, or vested and expected to vest as of September 28, 2012.

For the three and nine months ended September 28, 2012, 0.6 million and 1.5 million non-qualified stock option shares were exercised, respectively. The total intrinsic value of stock options exercised for the three and nine months ended September 28, 2012 was $10.1 million and $28.6 million, respectively. The aggregate intrinsic value represents the difference between the exercise price and the selling price received by option holders upon the exercise of stock options during the period. The total cash received from employees as a result of employee stock option exercises during the three and nine months ended September 28, 2012 was $11.4 million and $37.5 million, respectively.

ESPP

Our ESPP has two consecutive, overlapping twelve-month offering periods, with a new period commencing on the first trading day on or after May 1 and November 1 of each year and terminating on the last trading day on or before April 30 and October 31. Each twelve-month offering period generally includes two six-month purchase periods. The purchase price at which shares are sold under the ESPP is 85% of the lower of the fair market value of a share of our common stock on (1) the first day of the offering period, or (2) the last trading day of the purchase period. If the fair market value at the end of any purchase period is less than the fair market value at the beginning of the offering period, each participant is automatically withdrawn from the current offering period following the purchase of shares on the purchase date and is automatically re-enrolled in the immediately following offering period.

We sold 304,468 shares of common stock under the ESPP at a price of $30.23 during the nine months ended September 28, 2012, and 402,913 shares of common stock under the ESPP at a price of $22.40 during the nine months ended September 30, 2011. As of September 28, 2012, 3.2 million shares were available for future issuance under the ESPP.

VALUATION AND EXPENSE INFORMATION

The assumptions used to estimate the fair value of ESPP, RSUs and PRSUs were as follows:

Table of Contents



	Three Months Ended						Nine Months Ended
	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011

ESPP purchase rights:
Expected term (in years)	—			—			1.0			0.8
Expected stock price volatility	—			—			39.1		%	34.5		%
Risk-free interest rate	—			—			0.2		%	0.2		%
Dividend yield	—			—			0.9		%	0.5		%
Weighted-average estimated fair value	$	—		$	—		$	10.54		$	12.88

RSUs and PRSUs:
Risk-free interest rate	0.3		%	0.5		%	0.3		%	0.6		%
Dividend yield	1.1		%	0.8		%	1.0		%	0.7		%
Weighted-average estimated fair value	$	35.68		$	41.50		$	33.52		$	41.71

In addition, we apply an expected forfeiture rate when amortizing stock-based compensation expense. Our stock-based compensation expense included in the consolidated statements of comprehensive income for the three and nine months ended September 28, 2012 and September 30, 2011 was as follows:



	Three Months Ended						Nine Months Ended
(In thousands)	September 28, 2012			September 30, 2011			September 28, 2012			September 30, 2011

Cost of sales	$	492		$	450		$	1,416		$	1,200
Research and development expense	11,065			9,923			31,393			26,393
Selling, general, and administrative expense	13,033			12,178			37,981			32,390
Pre-tax stock-based compensation expense	24,590			22,551			70,790			59,983
Less: income tax benefit	(6,606		)	(5,907		)	(18,412		)	(16,210		)
Net stock-based compensation expense	$	17,984		$	16,644		$	52,378		$	43,773

No stock-based compensation was capitalized during any period presented above. As of September 28, 2012, unrecognized stock-based compensation cost related to outstanding unvested stock options, RSUs, PRSUs and ESPP shares that are expected to vest was approximately $181.3 million. This unrecognized stock-based compensation cost is expected to be recognized over a weighted average period of approximately 2.6 years. To the extent the actual forfeiture rate is different from what we have anticipated, stock-based compensation related to these awards will be different from that presented.

Note 13 — Income Taxes

Table of Contents

In addition, in 2010 the IRS completed field examinations for 2005 through 2007 and proposed an additional tax liability of $34.2 million, excluding interest. On January 23, 2012, the IRS issued a Statutory Notice of Deficiency, revising the assessment of additional taxes for 2005 through 2007 to $21.4 million, excluding interest. The Notice relates primarily to inter-company adjustments between related companies and reductions to the benefits of tax credit carrybacks and carryforwards to subsequent years. On April 20, 2012, we filed a petition in the U.S. Tax Court to request a redetermination of the tax deficiencies regarding certain IRS adjustments for 2005 through 2007. On June 21, 2012, the IRS filed its petition response in the Tax Court.

On August 15, 2012, the case for the 2004 tax year was combined with that for the 2005 through 2007 tax years. The case is currently scheduled for trial in March 2013. We believe we have made adequate tax payments or accrued adequate amounts for our tax liabilities for 2004 through 2007 and that the outcome of the above matters will not have a material adverse effect on our consolidated operating results, cash flows or financial position.

Other significant jurisdictions in which we are or may be subject to examination for fiscal years 2002 forward include China (including Hong Kong), Ireland, Malaysia, Japan, United Kingdom and the state of California. We believe we have made adequate tax payments and/or accrued adequate amounts such that the outcome of these audits will have no material adverse effect on our consolidated operating results. Due to the potential resolution of various tax examinations, and the expiration of various statutes of limitations, it is possible that our gross unrecognized tax benefits may change within the next twelve months. However, given the number of years remaining subject to examination and the number of matters being examined, we are unable to estimate the full range of possible adjustments to the balance of gross unrecognized tax benefits.

Our effective tax rate reflects the impact of a significant amount of our earnings being taxed in foreign jurisdictions at rates below the U.S. statutory tax rate.

Our effective tax rate for the three months ended September 28, 2012 was 11.3%, compared with 9.7% for the three months ended September 30, 2011. The net increase in our effective tax rate was primarily due to lower one-time tax benefits due primarily to the expiration of the statute of limitations in foreign jurisdictions in 2012 compared to 2011, partially offset by the absence of a U.S. federal research and development tax credit in 2012 due to its expiration in 2011. During the three months ended September 28, 2012, the effective tax rate includes a $3.9 million net tax benefit primarily associated with the release of liabilities for uncertain tax positions upon the expiration of foreign statutes of limitation and the reversal of the related interest accruals.

Our effective tax rate for the nine months ended September 28, 2012 was 4.0%, compared with 9.4% for the nine months ended September 30, 2011. The net decrease in our effective tax rate was primarily due to higher one-time tax benefits in 2012 compared to 2011, partially offset by the absence of a U.S. federal research and development tax credit in 2012, due to its expiration in 2011. During the nine months ended September 28, 2012, the effective tax rate includes the following net tax benefits associated with the release of liabilities for uncertain tax positions: 1) a $24.4 million net tax benefit primarily associated with the expiration of the federal statutes of limitation, the reassessment and recognition of previously unrecognized federal tax benefits, and the reversal of the related interest accruals; 2) a $6.9 million net tax benefit as a result of a Statutory Notice of Deficiency received from the IRS for 2005 to 2007; and 3) a $9.1 million net tax benefit as a result of the expiration of the statutes of limitations for certain foreign jurisdictions.

As of September 28, 2012, we had total gross unrecognized tax benefits of $263.9 million, if recognized, would impact our effective tax rate. On December 31, 2011, we had total gross unrecognized tax benefits of $284.9 million. We are unable to make a reasonable estimate as to when cash settlements with the relevant taxing authorities will occur.

We recognize interest and penalties related to uncertain tax positions in our income tax provision. We accrued approximately $47.6 million and $54.8 million for the payment of interest and penalties related to uncertain tax positions as of September 28, 2012 and December 31, 2011, respectively.

Note 14 — Non-Qualified Deferred Compensation Plan

We allow our U.S.-based officers and director-level employees to defer a portion of their compensation under the Altera Corporation Non-Qualified Deferred Compensation Plan (the “NQDC Plan”). Our Retirement Plans Committee administers the NQDC Plan. As of September 28, 2012, there were 123 participants in the NQDC Plan who self-direct their investments, subject to certain limitations. In the event we become insolvent, the NQDC Plan assets are subject to the claims of our general creditors. Since the inception of the NQDC Plan, we have not made any contributions to the NQDC Plan, and we have no commitments to do so in the future. There are no NQDC Plan provisions that provide for any guarantees or minimum return on investments. NQDC Plan participants are prohibited from investing NQDC Plan contributions in Altera common stock. The balance of the NQDC Plan assets and related obligations was $76.7 million and $72.0 million as of September 28, 2012 and December 31, 2011, respectively.

Investment income or loss earned by the NQDC Plan is recorded as (Gain) Loss on deferred compensation plan securities in our consolidated statements of comprehensive income. The investment (gain) loss also represents an (increase) decrease in the future payout to participants and is recorded as Compensation expense (benefit) — deferred compensation plan in our consolidated statements of comprehensive income. Compensation expense (benefit) associated with our NQDC Plan obligations is offset by the (gain) loss from related securities. The net effect of investment income or loss and related compensation expense or benefit has no impact on our income before income taxes, net income or cash balances.

The following tables summarize the fair value of our deferred compensation plan assets by significant investment category:



(In thousands)	September 28, 2012		December 31, 2011

Deferred compensation plan assets: (1)

Level 1:
Restricted cash equivalents	$	18,524	$	17,938
Equity securities	27,852		23,530
Mutual funds	26,895		25,375
Subtotal	73,271		66,843

Level 2:
Fixed income securities	3,404		5,136
Total	$	76,675	$	71,979

(1) Included in Deferred compensation plan - marketable securities and Deferred compensation plan - restricted cash equivalents in the accompanying consolidated balance sheets as of September 28, 2012 and December 31, 2011.

Note 15 — Subsequent Event

On October 15, 2012 our board of directors declared a quarterly cash dividend of $0.10 per common share, payable on December 3, 2012 to stockholders of record on November 13, 2012.

Table of Contents


ITEM 2:	Management's Discussion and Analysis of Financial Condition and Results of Operations

The following Management's Discussion and Analysis of Financial Condition and Results of Operations, as well as information contained in the risk factors described in Item 1A of this report and elsewhere in this report, contains forward-looking statements, which are provided under the “safe harbor” protection of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally written in the future tense and/or are preceded by words such as “will,” “may,” “should,” “could,” “expect,” “suggest,” “believe,” “anticipate,” “intend,” “plan,” or other similar words. Examples of forward-looking statements include statements regarding (1) our gross margins and factors that affect gross margins; (2) trends in our future sales; (3) our research and development expenditures and efforts; (4) our capital expenditures; (5) our provision for tax liabilities and other critical accounting estimates; and (6) our exposure to market risks related to changes in interest rates, equity prices and foreign currency exchange rates.

Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The forward-looking statements contained in this report are based on information that is currently available to us and expectations and assumptions that we deemed reasonable at the time the statements were made. We do not undertake any obligation to update any forward-looking statements in this report or in any of our other communications, except as required by law. All such forward-looking statements should be read as of the time the statements were made and with the recognition that these forward-looking statements may not be complete or accurate at a later date.

Many factors may cause actual results to differ materially from those expressed or implied by the forward-looking statements contained in this report. These factors include, but are not limited to, those risks described in Part II Item 1A of this report and those risks described under “Management's Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2011.

CRITICAL ACCOUNTING ESTIMATES

The preparation of our consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires our management to make judgments and estimates that affect the amounts reported in our consolidated financial statements and accompanying notes. Our management believes that we consistently apply these judgments and estimates and the consolidated financial statements and accompanying notes fairly represent all periods presented. However, any differences between these judgments and estimates and actual results could have a material impact on our consolidated statements of comprehensive income and financial position. Critical accounting estimates, as defined by the Securities and Exchange Commission (“SEC”), are those that are most important to the portrayal of our consolidated financial condition and results of operations and require our management's most difficult and subjective judgments and estimates of matters that are inherently uncertain. Our critical accounting estimates include those regarding (1) revenue recognition, (2) valuation of inventories, and (3) income taxes. For a discussion of our critical accounting estimates, see “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2011.

RESULTS OF OPERATIONS

Sales Overview

We design, manufacture, and market high-performance, high-density programmable logic devices, or PLDs; HardCopy® ASIC devices; pre-defined software design building blocks known as intellectual property cores, or IP cores; and associated development tools.

Our net sales of $495.0 million for the three months ended September 28, 2012, decreased by $27.5 million, or 5%, from our net sales of $522.5 million for the three months ended September 30, 2011. Our net sales of $1.3 billion for the nine months ended September 28, 2012 decreased by $263.1 million, or 16%, from our net sales of $1.6 billion for the nine months ended September 30, 2011. The decrease in net sales for the three-month period was a result of weakened demand in Europe, Japan and Asia Pacific, partially offset by growth in North America and declines in all other vertical markets with the exception of Telecom and Wireless which exhibited modest growth. For the nine months ended September 28, 2012, the decrease in net sales was a result of weakened demand in all geographies and vertical markets.

Net sales of new products increased as sales of 28 nm products accelerated strongly. The net sales of FPGAs and CPLDs as a percentage of total net sales for the three-month period remained consistent with the prior year. For the nine-month period,

Table of Contents

FPGAs increased modestly as a percentage of total net sales compared with CPLDs. For the three-month period, the Americas increased as a percentage of total net sales, partially offset by a decline in Japan with all other geographies essentially unchanged. For the nine-month period, Asia Pacific increased as a percentage of total net sales, partially offset by a decline in EMEA with all other geographies essentially unchanged.

Sales by Product Category

We classify our products into three categories: New, Mainstream, and Mature and Other Products. The composition of each product category is as follows:


•	New Products include the Stratix^® V (including GS, GT and GX), Stratix IV (including E, GX and GT), Arria^® V, Arria II (including GX and GZ), Cyclone^®V, Cyclone IV (including E and GX), MAX^® V and HardCopy^® IV devices.


•	Mainstream Products include the Stratix III, Cyclone III, MAX II and HardCopy III devices.


•	Mature and Other Products include the Stratix II (and GX), Stratix (and GX), Arria GX, Cyclone II, Cyclone, Classic™, MAX 3000A, MAX 7000, MAX 7000A, MAX 7000B, MAX 7000S, MAX 9000, HardCopy II, HardCopy, FLEX^® series, APEX™ series, Mercury™, and Excalibur™ devices, configuration and other devices, intellectual property cores and software and other tools.

Net sales by product category were as follows:



	Three Months Ended						Year- Over- Year Change		Sequential Change		Nine Months Ended				Year- Over- Year Change
	September 28, 2012		September 30, 2011		June 29, 2012		Year- Over- Year Change		Sequential Change		September 28, 2012		September 30, 2011		Year- Over- Year Change

New	31	%	27	%	31	%	8	%	8	%	29	%	20	%	16	%
Mainstream	32	%	32	%	30	%	(8	)%	13	%	31	%	34	%	(23	)%
Mature and Other	37	%	41	%	39	%	(12	)%	1	%	40	%	46	%	(27	)%
Net Sales	100	%	100	%	100	%	(5	)%	6	%	100	%	100	%	(16	)%

Sales by Vertical Market

The following vertical market data is derived from data that is provided to us by our distributors and end customers. With a broad base of customers, who in some cases manufacture end products spanning multiple market segments, the assignment of net sales to a vertical market requires the use of estimates, judgment and extrapolation. As such, actual results may differ from those reported.



	Three Months Ended						Year- Over- Year Change		Sequential Change		Nine Months Ended				Year- Over- Year Change
	September 28, 2012		September 30, 2011		June 29, 2012		Year- Over- Year Change		Sequential Change		September 28, 2012		September 30, 2011		Year- Over- Year Change

Telecom & Wireless	45	%	42	%	45	%	2	%	7	%	44	%	43	%	(15	)%
Industrial Automation, Military & Automotive	20	%	22	%	19	%	(11	)%	11	%	21	%	22	%	(24	)%
Networking, Computer & Storage	17	%	20	%	18	%	(21	)%	5	%	17	%	17	%	(13	)%
Other	18	%	16	%	18	%	3	%	3	%	18	%	18	%	(13	)%
Net Sales	100	%	100	%	100	%	(5	)%	6	%	100	%	100	%	(16	)%

Table of Contents

Sales of FPGAs and CPLDs

Our PLDs consist of field-programmable gate arrays, or FPGAs, and complex programmable logic devices, or CPLDs. FPGAs consist of our Stratix, Cyclone, Arria, APEX, FLEX and ACEX 1K, as well as our Excalibur and Mercury families. CPLDs consist of our MAX, MAX II, MAX V and Classic families. Other Products consist of our HardCopy series and other masked programmed logic devices, configuration devices, software and other tools and IP cores.

Our net sales of FPGAs, CPLDs, and Other Products were as follows:



	Three Months Ended						Year- Over- Year Change		Sequential Change		Nine Months Ended				Year- Over- Year Change
	September 28, 2012		September 30, 2011		June 29, 2012		Year- Over- Year Change		Sequential Change		September 28, 2012		September 30, 2011		Year- Over- Year Change

FPGA	82	%	82	%	85	%	(5	)%	4	%	83	%	81	%	(14	)%
CPLD	9	%	9	%	9	%	(9	)%	4	%	9	%	10	%	(24	)%
Other Products	9	%	9	%	6	%	(6	)%	45	%	8	%	9	%	(29	)%
Net Sales	100	%	100	%	100	%	(5	)%	6	%	100	%	100	%	(16	)%

Sales by Geography

The following table is based on the geographic location of the original equipment manufacturers or the distributors who purchased our products. The geographic location of distributors may be different from the geographic location of the ultimate end users.

Net sales by geography were as follows:



	Three Months Ended						Year- Over- Year Change		Sequential Change		Nine Months Ended				Year- Over- Year Change
	September 28, 2012		September 30, 2011		June 29, 2012		Year- Over- Year Change		Sequential Change		September 28, 2012		September 30, 2011		Year- Over- Year Change

Americas	19	%	16	%	17	%	6	%	15	%	18	%	19	%	(20	)%
Asia Pacific	43	%	44	%	46	%	(6	)%	1	%	44	%	41	%	(10	)%
EMEA	25	%	25	%	23	%	(5	)%	18	%	24	%	26	%	(23	)%
Japan	13	%	15	%	14	%	(16	)%	(4	)%	14	%	14	%	(17	)%
Net Sales	100	%	100	%	100	%	(5	)%	6	%	100	%	100	%	(16	)%

Price Concessions and Product Returns from Distributors

We sell the majority of our products to distributors worldwide at a list price. However, distributors resell our products to end customers at a very broad range of individually negotiated prices based on a variety of factors, including customer, product, quantity, geography and competitive differentiation. The majority of our distributors' sales to their customers are priced at a discount from our list price. Under these circumstances, we remit back to the distributor a portion of its original purchase price after the resale transaction is completed and we validate the distributor's resale information, including end customer, device, quantity and price, against the distributor price concession that we have approved in advance. To receive price concessions, distributors must submit the price concession claims to us for approval within 60 days of the resale of the product to an end customer. Primarily because of the uncertainty related to the final price, we defer revenue recognition on sales to distributors until our products are sold from the distributor to the end customer, which is when our price is fixed or determinable. Accordingly, these pricing uncertainties impact our results of operations, liquidity and capital resources. Average aggregate price concessions typically range from 65% to 80% of our list price on an annual basis, depending upon the composition of our sales, volume and factors associated with timing of shipments to distributors. Total price concessions earned by distributors were $3.1 billion and $3.0 billion for the nine months ended September 28, 2012 and September 30, 2011, respectively.

Table of Contents

Our distributors have certain rights under our contracts to return defective, overstocked, obsolete or discontinued products. Our stock rotation program generally allows distributors to return unsold product to Altera, subject to certain contract limits, based on a percentage of sales occurring over various periods prior to the stock rotation. Products resold by the distributor to end customers are no longer eligible for return, unless specifically authorized by us. In addition, we generally warrant our products against defects in material, workmanship and non-conformance to our specifications. Returns from distributors totaled $61.5 million and $111.9 million for the nine months ended September 28, 2012 and September 30, 2011, respectively.

Gross Margin



	Three Months Ended						Nine Months Ended
	September 28, 2012		September 30, 2011		June 29, 2012		September 28, 2012		September 30, 2011

Gross Margin Percentage	69.3	%	68.0	%	69.6	%	69.6	%	70.5	%

Gross margin rates are heavily influenced by both vertical market mix and the timing of material cost improvements. While these variables will continue to fluctuate on a quarterly basis, our gross margin target over the long term is 67%. We believe that the 67% gross margin target will enable us to achieve our desired balance between growth and profitability. Our gross margin percentage for the three months ended September 28, 2012 increased by 1.3 points compared with the same period of 2011. The increase is primarily due to our improved Telecom and Wireless product mix when compared with the same period of 2011. Our gross margin percentage for the nine months ended September 28, 2012 decreased by 0.9 points compared to the same period of 2011 which was attributable to an unfavorable vertical market mix when compared with the same period of 2011.

Research and Development Expense

Research and development expense includes costs for compensation and benefits, development masks, prototype wafers, and depreciation and amortization. These expenditures are for the design of new PLD and ASIC families, the development of process technologies, new package technology, software to support new products and design environments and IP cores.

We will continue to make significant investments in the development of new products and focus our efforts on the development of new programmable logic devices that use advanced semiconductor wafer fabrication processes, as well as related development software. We are currently investing in the development of future silicon products, as well as our Quartus® II software, our library of IP cores and other future products.



	Three Months Ended									Year- Over- Year Change		Sequential Change		Nine Months Ended						Year- Over- Year Change
(In millions)	September 28, 2012			September 30, 2011			June 29, 2012			Year- Over- Year Change		Sequential Change		September 28, 2012			September 30, 2011			Year- Over- Year Change

Research and Development Expense	$	91.6		$	80.8		$	92.4		13	%	(1	)%	$	266.3		$	235.4		13	%
Percentage of Net Sales	18.5		%	15.5		%	19.9		%					19.8		%	14.7		%

Research and development expense for the three months ended September 28, 2012 increased by $10.8 million, or 13.4% , compared with the three months ended September 30, 2011. The increase was primarily attributable to a $6.8 million increase in personnel-related costs due to an increase in the number of employees, a $1.1 million increase in stock-based compensation driven by an increase in employees and, an $8.7 million increase in spending on product development activities. These increases were partially offset by a $6.4 million decrease in variable compensation expense based on lower operating results in 2012.

Research and development expense for the nine months ended September 28, 2012 increased $30.9 million, or 13.1%, compared with the nine months ended September 30, 2011. The increase was primarily due to a $17.4 million increase in personnel-related costs attributed to an increase in the number of employees, a $5.0 million increase in stock-based compensation driven by an increase in employees, and a $26.3 million increase in spending on product development activities. These increases were partially offset by a $19.6 million decrease in variable compensation expense based on lower operating results in 2012.

Selling, General, and Administrative Expense

Table of Contents

Selling, general, and administrative expense includes costs for compensation and benefits related to sales, marketing, and administrative employees, commissions and incentives, depreciation, legal, advertising, facilities and travel expenses.



	Three Months Ended									Year- Over- Year Change		Sequential Change		Nine Months Ended						Year- Over- Year Change
(In millions)	September 28, 2012			September 30, 2011			June 29, 2012			Year- Over- Year Change		Sequential Change		September 28, 2012			September 30, 2011			Year- Over- Year Change

Selling, General and Administrative Expense	$	74.2		$	69.3		$	71.8		7	%	3	%	$	215.8		$	208.6		3	%
Percentage of Net Sales	15.0		%	13.3		%	15.4		%					16.1		%	13.0		%

Selling, general, and administrative expense for the three months ended September 28, 2012 increased by $4.9 million, or 7%, compared with the three months ended September 30, 2011. The increase was primarily attributable to a $1.7 million increase in personnel-related costs due to an increase in the number of employees, a $0.9 million increase in stock-based compensation driven by an increase in employees, a $2.9 million increase in professional services and consulting fees and a $2.2 million increase in information technology infrastructure upgrades and projects. These increases were partially offset by a $3.4 million decrease in variable compensation expense based on lower operating results in 2012.

Selling, general, and administrative expense for the nine months ended September 28, 2012 increased by $7.2 million, or 3%, compared with the nine months ended September 30, 2011. The increase was primarily attributable to a $4.5 million increase in personnel-related costs due to an increase in the number of employees, a $5.6 million increase in stock-based compensation driven by an increase in employees, a $6.2 million increase in professional services and consulting fees, and a $3.5 million increase in information technology infrastructure upgrades and projects. These increases were partially offset by a $10.9 million decrease in variable compensation expense based on lower operating results in 2012.

Deferred Compensation Plan

We allow our U.S.-based officers and director-level employees to defer a portion of their compensation under the Altera Corporation Non-Qualified Deferred Compensation Plan (the “NQDC Plan”). Since the inception of the NQDC Plan, we have not made any contributions to the NQDC Plan and we have no commitments to do so in the future. There are no NQDC Plan provisions that provide for any guarantees or minimum return on investments. Investment income or loss earned by the NQDC Plan is recorded as Gain on deferred compensation plan securities in our consolidated statements of comprehensive income. We reported net investment gains of $3.3 million and $6.7 million on NQDC Plan assets for the three and nine months ended September 28, 2012, respectively. We reported net investment losses of $6.6 million and $4.9 million on NQDC Plan assets for the three and nine months ended September 30, 2011, respectively. These amounts resulted from the overall market performance of the underlying securities. The investment (gain)/loss also represents an (increase)/decrease in the future payout to employees and is recorded as Compensation expense/(benefit) — deferred compensation plan in our consolidated statements of comprehensive income. The compensation expense/(benefit) associated with our deferred compensation plan obligations is offset by (gains) losses from related securities. The net effect of the investment income or loss and related compensation expense or benefit has no impact on our income before income taxes, net income or cash balances. See Note 14 — Non-Qualified Deferred Compensation Plan to our consolidated financial statements for a detailed discussion of the NQDC Plan.

Interest Income and Other

Interest income and other, consisting mainly of interest income generated from investments in high-quality fixed income securities, increased by $2.1 million and $3.5 million, respectively, for the three and nine months ended September 28, 2012 when compared with the same period in 2011, primarily due to higher cash and investments and changes in our investment portfolio elections during 2012 that generated higher investment income.

Interest Expense

The increase in Interest expense by $1.5 million and $2.7 million, for the three and nine months ended September 28, 2012, respectively, when compared to the same periods in the prior year, was due primarily to the new long-term debt, which has a higher effective interest rate than the former credit facility. See Note 10 - Credit Facility and Long-Term Debt to our consolidated financial statements.

Table of Contents

Income Tax Expense

Our effective tax rate reflects the impact of a significant amount of our earnings being taxed in foreign jurisdictions at rates below the U.S. statutory tax rate.

Our effective tax rate for the nine months ended September 28, 2012 was 4.0%, compared with 9.4% for the nine months ended September 30, 2011. The net decrease in our effective tax rate was primarily due to higher one-time tax benefits in 2012 compared to 2011, partially offset by the absence of a U.S. federal research and development tax credit in 2012 due to its expiration in 2011. During the nine months ended September 28, 2012, the effective tax rate includes the following net tax benefits associated with the release of liabilities for uncertain tax positions: 1) a $24.4 million net tax benefit primarily associated with the expiration of the federal statutes of limitation, the reassessment and recognition of previously unrecognized federal tax benefits, and the reversal of the related interest accruals; 2) a $6.9 million net tax benefit as a result of a Statutory Notice of Deficiency received from the IRS for 2005 to 2007; and 3) a $9.1 million net tax benefit as a result of the expiration of the statutes of limitations for certain foreign jurisdictions.

As of September 28, 2012, we had $263.9 million of unrecognized tax benefits that, if recognized, would impact our effective tax rate. On December 31, 2011, we had $284.9 million of unrecognized tax benefits. We are unable to make a reasonable estimate as to when cash settlements with the relevant taxing authorities will occur.

See Note 13 - Income Taxes to our consolidated financial statements for further discussion.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We derive our liquidity and capital resources primarily from our cash flows from operations. We continue to generate strong positive operating cash flows. In May 2012, we issued 1.75% senior notes that will mature on May 15, 2017 (the “Notes”) in the aggregate principal amount of $500 million. We used the net proceeds to repay our former credit facility. In June 2012, we entered into a credit agreement that provides for a $250 million unsecured revolving line of credit (the "Facility"), which is scheduled to mature in June 2017. As of September 28, 2012, we had no borrowings under the Facility. As such, the $250 million available under the Facility represents a source of liquidity. See Note 10 - Credit Facility and Long-Term Debt to our consolidated financial statements for further discussion.

We currently use cash to fund dividends, capital expenditures and for repurchases of our common stock. Based on past performance and current expectations, we believe that our current available sources of funds (including cash, cash equivalents, short-term investments and the Facility, plus anticipated cash generated from operations) will be adequate to finance our operations, cash dividends, capital expenditures and stock repurchases for at least the next year.

Our cash and cash equivalents balance during the nine months ended September 28, 2012 decreased by $522.1 million. The change in cash and cash equivalents during the nine months ended September 28, 2012 and September 30, 2011 was as follows:

Table of Contents



	Nine Months Ended
(In thousands)	September 28, 2012			September 30, 2011

Net cash provided by operating activities	$	460,505		$	739,237
Net cash used in investing activities	(742,513		)	(151,229		)
Net cash used in financing activities	(240,096		)	(175,890		)
Net (decrease) increase in cash and cash equivalents	$	(522,104	)	$	412,118

Operating Activities

For the nine months ended September 28, 2012, our operating activities provided $460.5 million in cash, primarily attributable to net income of $436.0 million, adjusted for non-cash stock-based compensation expense of $64.4 million (net of related tax effects), depreciation and amortization of $26.4 million, and a deferred income tax benefit of $3.4 million. The net change in working capital accounts (excluding cash and cash equivalents) was primarily due to a $116.0 million increase in Accounts receivable, net, a $35.6 million increase in Inventories, a $5.5 million increase in Other assets, a $34.7 million decrease in Accounts payable and other liabilities, a $120.5 million increase in deferred income and allowances on sales to distributors, and a $0.7 million decrease in Income taxes payable.

Our sales to distributors are primarily made under agreements allowing for subsequent price adjustments and returns, and we defer recognition of revenue until the products are resold by the distributor. At the time of shipment to distributors, we (1) record a trade receivable at the list selling price since there is a legally enforceable obligation from the distributor to pay us currently for product delivered, (2) relieve inventory for the carrying value of goods shipped since legal title has passed to the distributor and (3) record deferred revenue and deferred cost of sales in Deferred income and allowances on sales to distributors in the liability section of our consolidated balance sheets. Accordingly, increases in Accounts receivable, net associated with higher billings are generally offset by corresponding increases in Deferred income and allowances on sales to distributors. However, timing differences between gross billings, advances to distributors, discounts earned, collections, revenue recognition and changes in the mix of sales to OEMs and distributors may result in a temporary interruption to the normal relationship between these two accounts.

The $116.0 million increase in Accounts receivable, net, and the $120.5 million increase in Deferred income and allowances on sales to distributors, principally relates to increased gross billings to distributors and OEMs, associated with an upward trend in demand for certain products during the period.

The $35.6 million increase in Inventories is attributable to increased production of new products near the end of the period.

The $5.5 million increase in Other assets primarily resulted from the increase in deferred financing costs, offset by a decrease in prepaid income taxes and other prepaid items.

The $34.7 million decrease in Accounts payable and other liabilities was attributable to a decrease in the accrual for variable compensation, and a decrease in inventory purchases due to the management of our inventory levels, partially offset by an increase in other accrued liabilities.

The $0.7 million decrease in Income taxes payable was related to the net impact of the reversal of liabilities for uncertain tax positions offset by additional accrued tax liabilities associated with current earnings.

Investing Activities

Cash used in investing activities in the nine months ended September 28, 2012, primarily consisted of purchases of available for sale securities of $819.7 million, purchases of property and equipment of $53.7 million and purchases of intangible assets and other investments of $6.8 million, partially offset by net sales and maturities of available for sale securities of $135.7 million.

Table of Contents

Financing Activities

Cash used in financing activities in the nine months ended September 28, 2012, primarily consisted of the repayment of our former credit facility in the aggregate principal amount of $500.0 million, repurchases of common stock of $179.1 million, cash dividend payments of $83.6 million and minimum statutory withholding for vested restricted stock units of $30.5 million. These items were substantially offset by proceeds of $500.0 million from the issuance of long-term debt and proceeds of $37.5 million from the issuance of common stock to employees through our employee stock plans and the excess tax benefit from stock-based compensation of $20.8 million.

Our dividend policy could be impacted in the future by, among other items, future changes in our cash flows from operations and our capital spending needs such as those relating to research and development, investments and acquisitions, common stock repurchases, and other strategic investments.

CONTRACTUAL OBLIGATIONS

As of September 28, 2012, we had $6.5 million of non-cancelable license obligations to providers of electronic design automation software and maintenance expiring at various dates throughout December 2014.

We lease facilities under non-cancelable lease agreements expiring at various times through 2021. There have been no significant changes to our operating lease obligations since December 31, 2011.

In addition to these lease and purchase obligations, we enter into, in the normal course of business, a variety of agreements and financial commitments. It is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments pursuant to such agreements have not been material. We believe that any future payments required pursuant to such agreements would not be significant to our consolidated financial position or operating results.

As of September 28, 2012, we had a liability for unrecognized tax benefits of $261.8 million. Due to the uncertainty with respect to the timing of future cash flows associated with our unrecognized tax benefits as of September 28, 2012, we are unable to make a reasonably reliable estimate as to when cash settlements with the relevant taxing authorities will occur.

OFF-BALANCE SHEET ARRANGEMENTS

As of September 28, 2012, we did not have any off-balance sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

SUBSEQUENT EVENTS

On October 15, 2012, our board of directors declared a quarterly cash dividend of $0.10 per common share, payable on December 3, 2012 to stockholders of record on November 13, 2012.

RECENT ACCOUNTING PRONOUNCEMENTS

The information contained in Note 2 - Recent Accounting Pronouncements to our consolidated financial statements in Part I, Item 1 is incorporated by reference into this Part I, Item 2.

Table of Contents

ITEM 3: Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

While we are exposed to interest rate fluctuations in many of the world's leading industrialized countries, our interest income is most sensitive to fluctuations in the general level of U.S. interest rates. Our investment strategy is focused on preservation of capital while supporting our liquidity requirements. Our exposure to market risk as a result of changes in interest rates relates primarily to our cash and cash equivalents, investments in debt instruments and certain interest rate sensitive assets held under the NQDC Plan. Our investment portfolio and NQDC Plan assets include holdings of various issuers, types and maturity dates.

The market value of these investments on any given day during the investment term may vary as a result of market interest rate fluctuations. A hypothetical 10% movement in interest rates during the investment term would not have a material impact on the fair value of the portfolio. The actual impact on the fair value of the portfolio in the future may differ materially from this analysis, depending on actual balances and changes in the timing and the amount of interest rate movements.

In May 2012, we issued $500 million aggregate principal amount of 1.75% senior notes due May 15, 2017 (the “Notes”). The fair market value of long-term fixed interest rate debt is subject to interest rate risk. Generally, the fair market value of fixed interest rate debt will increase as interest rates fall and decrease as interest rates rise. The estimated fair value of Altera's long-term debt was approximately $515.7 million at September 28, 2012.

Our consolidated operating results are affected by, among other factors, interest income on our cash equivalents. If the interest rate declines, our consolidated operating results may be negatively impacted.

Equity Price Risk

We are exposed to equity price risk inherent in the marketable equity securities held in our NQDC Plan. A hypothetical 10% adverse change in the stock prices of these equity securities would not result in a material impact on our consolidated financial position, operating results or cash flows.

Foreign Currency Risk

We have international operations and incur expenditures in currencies other than U.S. dollars. To date, our exposure to exchange rate volatility, resulting from foreign currency transaction gains and losses and remeasurement of local currency assets and liabilities into U.S. dollars, has been insignificant. If foreign currency rates were to fluctuate by 10% from rates in effect at September 28, 2012, the resulting transaction gains or losses and the effects of remeasurement would not materially affect our consolidated financial position, operating results or cash flows.

Table of Contents


ITEM 4:	Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, as amended, as of the end of the period covered by this Quarterly Report on Form 10-Q (the “Evaluation Date”).

The purpose of this evaluation was to determine if, as of the Evaluation Date, our disclosure controls and procedures were designed and operating effectively to provide reasonable assurance that the information relating to Altera, required to be disclosed in our Exchange Act filings (i) was recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) was accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on the evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of the Evaluation Date, our disclosure controls and procedures were effective at a reasonable assurance level.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a - 15(f) and 15(d) - 15(f) under the Exchange Act) that occurred during the period covered by this quarterly report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitation on Effectiveness of Controls

It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. The design of any control system is based, in part, upon the benefits of the control system relative to its costs. Control systems can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. In addition, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies and procedures may deteriorate. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events.

PART II OTHER INFORMATION


ITEM 1:	Legal Proceedings

This information is included in Note 11 — Commitments and Contingencies to our consolidated financial statements in Part I, Item 1 of this report and is incorporated herein by reference.


ITEM 1A:	Risk Factors

There have been no material changes from the risk factors previously described under Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011. For additional information regarding risk factors, please refer to the description of the risk factors associated with our business previously disclosed in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011.

Before you decide to buy, hold or sell our common stock, you should carefully consider the risks described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011 and the other information contained elsewhere in this report. These risks are not the only risks facing our company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business. Our business, consolidated operating results and financial position could be seriously harmed if any of the events underlying any of these risks or uncertainties actually occurs. In that event, the market price for our common stock could decline, and you may lose all or part of your investment.

Table of Contents


ITEM 2:	Unregistered Sales of Equity Securities and Use of Proceeds

Items 2(a) and 2(b) are inapplicable.

2(c) Issuer Purchases of Equity Securities

We have an ongoing authorization from our board of directors to repurchase up to 203.0 million shares of our common stock. As of September 28, 2012, we had repurchased 188.4 million shares for an aggregate cost of $4.0 billion. No existing repurchase plans or programs have expired, nor have we decided to terminate any repurchase plans or programs prior to expiration.

During the three-month period ended September 28, 2012, we repurchased shares of our common stock as follows:



(Shares are presented in thousands)
Period	Total Number of Shares Purchased⁽¹⁾	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs⁽²⁾
7/2/2012-7/27/2012	1,602	$	31.22	1,602	14,601
	1,602			1,602

(1) No shares were purchased outside of publicly announced plans or programs.

(2) An additional 10 million shares were approved by the board of directors in July 2012.

For the majority of the restricted stock units that we grant, the number of shares issued on the date the restricted stock units vest is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. Although these withheld shares are not issued or considered common stock repurchases under our authorized plan and are not included in the common stock repurchase totals in the preceding table, they are treated as common stock repurchases in our financial statements, as they reduce the number of shares that would have been issued upon vesting.

Table of Contents


ITEM 6:	Exhibits




Exhibit No.		Description

*31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

*31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

#32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

#32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

_________________

*Filed herewith

#Furnished herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	ALTERA CORPORATION

	By:	/s/ RONALD J. PASEK
		Ronald J. Pasek
		Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

Table of Contents

EXHIBIT INDEX




Exhibit No.		Description

*31.1		Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

*31.2		Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934

#32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

#32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

_________________

*Filed herewith

#Furnished herewith